Pharmaceutical Caps and Closure Packaging Market
Pharmaceutical Caps and Closure Packaging Market by Type (Screw Caps, Crimp-ons, Press-ons, Roll-ons, Frictions), Material (Plastic, Elastomer, Metal), Packaging Type (Child-resistant, Tamper-evident, End User, and Region - Global Forecast to 2030
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global pharmaceutical caps and closure packaging market was valued at USD 16.15 billion in 2025 and is expected to reach USD 32.77 billion by 2030, growing at a CAGR of 15.0% during the forecast period. Pharmaceutical caps and closures are essential packaging components designed to protect pharmaceutical products from contamination, ensure product integrity, and maintain compliance with stringent regulatory requirements. These packaging solutions encompass various closure types, including screw caps, crimp-ons, press-ons, roll-ons, and friction closures that serve critical functions in preserving drug efficacy and patient safety. Market growth is driven by increasing demand for secure and sustainable packaging solutions, technological advancements in packaging materials, the rise in pharmaceutical contract manufacturing, and innovative design implementations that address both safety and compliance requirements across the pharmaceutical industry.
KEY TAKEAWAYS
-
By RegionNorth America led the pharmaceutical caps and closure packaging market, valued at USD 4.7 billion in 2025, and is projected to grow at a CAGR of 14.5% during the forecast period.
-
By MaterialPlastic dominates due to cost efficiency and versatility, accounting for 55% share of the overall market in 2024.
-
By ApplicationScrew caps and closures represent the dominant application segment, accounting for 45% share of the pharmaceutical caps & closure packaging market in 2024.
-
By Packaging TypeChild-resistant packaging is the largest segment with a share of 28% of the overall market in 2024.
-
Competitive Landscape - Star PlayersAmcor plc (Switzerland), Gerresheimer AG (Germany), AptarGroup (US), West Pharmaceutical Services (US), and Silgan Holdings (US) were identified as leading players in the pharmaceutical caps and closure packaging market, given their strong market presence, extensive product portfolios, and continuous innovation through new product launches and strategic collaborations.
-
Competitive Landscape - StartupsWeener Plastics Group and Bericap have distinguished themselves through specialized capabilities in digitally networked closures and advanced compliance solutions, underscoring their potential as emerging market leaders in innovative pharmaceutical caps and closure packaging technologies.
The global pharmaceutical caps and closure packaging market is experiencing robust growth driven by increasing regulatory requirements for drug safety and the expanding pharmaceutical manufacturing sector worldwide.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The pharmaceutical caps and closure packaging market is currently experiencing a phase of innovation and rapid adoption driven by evolving regulatory frameworks and patient safety requirements. Healthcare systems and pharmaceutical manufacturers across North America, Europe, Asia Pacific, and other regions are witnessing advancements in closure technology development and regulatory compliance. This progress aligns with emerging trends in child-resistant packaging, tamper-evident solutions, and digitally networked closures for improved medication administration monitoring. In the pharmaceutical industry, the use of advanced materials such as polypropylene and polyethylene is increasing among drug manufacturers and contract packaging organizations. These materials facilitate the development of closures that ensure drug preservation, reduce contamination risks, and align with regulatory guidelines mandated by the FDA and CPSC. Governments and regulatory bodies are encouraging innovation in packaging design, the development of digitally integrated closures for patient compliance monitoring, and public-private research programs. These initiatives help accelerate approval timelines and promote the adoption of technologically advanced, clinically validated closure platforms tailored to the needs of diverse pharmaceutical applications and patient populations.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing focus on drug preservation and safety facilitated by stringent regulatory frameworks
-
Growing demand for child-resistant and tamper-evident packaging solutions
Level
-
Fluctuating raw material prices and high costs associated with implementing advanced technologies
Level
-
Expanding pharmaceutical contract manufacturing sector and demand for small and medium-sized closures
Level
-
Maintaining balance between innovation and cost efficiency while countering proliferation of counterfeit drugs
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing focus on drug preservation and safety facilitated by stringent regulatory frameworks
The increasing focus on drug preservation and patient safety across the pharmaceutical industry, supported by stringent regulatory frameworks such as the FDA and CPSC guidelines mandating child-resistant packaging, is driving greater adoption of advanced caps and closures. Pharmaceutical manufacturers and packaging companies are investing in innovative closure technologies that ensure product integrity, prevent contamination, and comply with evolving safety standards, which is increasing the use of specialized caps and closures in pharmaceutical packaging applications.
Restraint: Fluctuating raw material prices and high costs associated with implementing advanced technologies
Fluctuating raw material prices and the high costs associated with implementing advanced packaging technologies restrict the adoption of innovative pharmaceutical caps and closures. Price volatility in polypropylene, polyethylene, and other packaging materials, combined with significant capital investment requirements for advanced manufacturing capabilities, create challenges for manufacturers trying to introduce cost-effective yet technologically sophisticated closure solutions across the market.
Opportunity: Expanding pharmaceutical contract manufacturing sector and demand for small and medium-sized closures
The expanding pharmaceutical contract manufacturing sector and growing demand for small and medium-sized closures present significant growth opportunities in the pharmaceutical packaging market. These specialized closure solutions are increasingly utilized in contract packaging operations, specialized drug formulations, and personalized medicine applications, aligning well with the industry focus on flexible manufacturing and customized packaging solutions.
Challenge: Maintaining balance between innovation and cost efficiency while countering proliferation of counterfeit drugs
Maintaining a balance between innovation and cost efficiency remains a key challenge while simultaneously addressing the proliferation of counterfeit drugs in the pharmaceutical supply chain. Manufacturers must invest in advanced anti-counterfeiting technologies, quality control systems, and compliance validation to ensure product authenticity and patient safety while managing production costs and maintaining competitive pricing for pharmaceutical caps and closure solutions.
PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Amcor plc supplies innovative pharmaceutical packaging solutions, including the AmSky packaging system and advanced closure technologies, to pharmaceutical manufacturers across North America, Europe, and the Asia Pacific for drug preservation, contamination prevention, and regulatory compliance in various pharmaceutical applications | Ensures superior product protection, maintains drug efficacy, supports regulatory compliance, and enables secure packaging for diverse pharmaceutical products while meeting stringent safety and quality standards. |
 |
Gerresheimer AG provides high-precision pharmaceutical caps and closures, including the Gx Cap digital closure system to pharmaceutical companies and contract manufacturers for enhanced patient compliance monitoring, medication administration tracking, and advanced drug packaging applications. | Delivers enhanced patient compliance capabilities, supports digital health integration, provides tamper-evident security, and enables pharmaceutical companies to meet evolving regulatory requirements and patient safety standards. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The pharmaceutical caps and closure packaging market is a collaborative ecosystem where packaging material suppliers, pharmaceutical manufacturers, contract packaging organizations, technology providers, and healthcare professionals work together to develop and implement advanced closure solutions in the pharmaceutical sector. Companies in the market supply a variety of caps and closures, including screw caps, crimp-ons, press-ons, roll-ons, and friction closures manufactured from materials such as polypropylene, polyethylene, and other specialized polymers. Contract development and manufacturing organizations, pharmaceutical companies, and packaging specialists across North America, Europe, Asia Pacific, South America, and the Middle East and Africa support the development, testing, and scale-up process for these packaging solutions. Ultimately, pharmaceutical manufacturers and healthcare providers utilize the developed caps and closures, benefiting from supportive regulations, safety guidelines, and quality standards that ensure product integrity and patient safety.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Pharmaceutical Caps and Closure Packaging Market, by Material
The pharmaceutical caps and closure packaging market is currently experiencing its fastest growth through plastic caps and closures because these products provide lightweight design and cost-effective value, and they can be used to package various oral solid, liquid, and over-the-counter medications products. The market expansion results from two main factors: the growing need for child-resistant and tamper-proof packaging and the development of advanced polymers that provide better chemical protection and reduced substance transfer. The increasing use of sustainable, recyclable plastic solutions, together with growing pharmaceutical production in developing countries, drives the adoption of plastic closure systems.
Pharmaceutical Caps and Closure Packaging Market, by Application
Screw caps and closures represented the largest segment of the pharmaceutical caps and closure packaging market. The increasing demand for child-resistant and tamper-evident packaging has propelled this segment to the forefront in the industry. Factors such as stringent regulatory requirements mandated by the FDA and CPSC, growing concerns about medication safety, patient compliance needs, and the prevention of accidental ingestion are driving the demand for advanced screw cap closures, child-resistant packaging solutions, and tamper-evident closure systems.
REGION
North America to maintain leadership position in market during forecast period
North America is the leading region in the pharmaceutical caps and closure packaging market, valued at USD 4.70 billion in 2025 and is projected to grow at a CAGR of 14.5% between 2025 and 2030, driven by stringent safety regulations, well-established pharmaceutical manufacturing infrastructure, and strong regulatory frameworks governing pharmaceutical packaging. The demand for child-resistant closures, tamper-evident packaging, and advanced closure technologies is increasing across the region, driven by FDA and CPSC guidelines mandating specific safety features for pharmaceutical products. Additionally, significant investment in pharmaceutical contract manufacturing, combined with a mature healthcare system and a focus on patient safety, is facilitating the continued adoption of innovative caps and closures from research and development to commercial implementation.
PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET: COMPANY EVALUATION MATRIX
Amcor plc, recognized as a leading player in the pharmaceutical caps and closure packaging market, offers a diverse portfolio that includes innovative closure systems, child-resistant packaging, tamper-evident solutions, and the AmSky packaging technology for pharmaceutical applications. The company boasts a strong manufacturing presence globally and collaborates with pharmaceutical manufacturers, contract packaging organizations, and healthcare providers across North America, Europe, the Asia Pacific, and other regions. Another significant player in the market is Gerresheimer AG, identified as a leading innovator. The company is strengthening its position by introducing advanced closure technologies, including the Gx Cap high-precision digital closure system, bioresorbable materials, and specialty packaging solutions designed for enhanced patient compliance, medication monitoring, and diverse pharmaceutical applications.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Amcor plc (Switzerland)
- Gerresheimer AG (Germany)
- AptarGroup (US)
- West Pharmaceutical Services (US)
- Silgan Holdings (US)
- Weener Plastics Group (Netherlands)
- Bericap (Germany)
- Closure Systems International (US)
- Bormioli Pharma (Italy)
- Guala Closures (Italy)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 16.15 Billion |
| Market Forecast in 2030 (Value) | USD 32.77 Billion |
| Growth Rate | CAGR of 15.0% from 2025–2030 |
| Years Considered | 2022–2030 |
| Base Year | 2024 |
| Forecast Period | 2025–2030 |
| Units Considered | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
WHAT IS IN IT FOR YOU: PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Understanding demand patterns for pharmaceutical caps and closures across global pharmaceutical manufacturing systems | Assessed pharmaceutical caps and closure usage trends across key regions, including North America, Europe, Asia Pacific, South America, and the Middle East and Africa, highlighting differences in the adoption of screw caps, crimp-ons, press-ons, roll-ons, and friction closures across various pharmaceutical applications and regulatory environments | Helps clients align product portfolios with region-specific regulatory requirements, material preferences, safety standards, and pharmaceutical manufacturing volumes |
| Identifying material sourcing and manufacturing opportunities | Mapped regional pharmaceutical packaging suppliers, contract manufacturers, and closure technology providers across North America, Europe, and the Asia Pacific, with insights into polypropylene and polyethylene processing, advanced closure manufacturing, child-resistant technology implementation, and pharmaceutical-grade material supply | Supports localization strategies, reduces supply-chain risk, lowers production costs, ensures regulatory compliance, and improves speed-to-market for pharmaceutical packaging solutions |
RECENT DEVELOPMENTS
- October 2023 : Gerresheimer AG launched Gx Cap, a high-precision digital closure system designed for enhanced patient compliance monitoring and medication administration tracking, demonstrating advanced technological integration and improved functionality for pharmaceutical packaging applications.
- March 2023 : Amcor plc entered a strategic partnership with Berry Global to enhance its healthcare packaging segment, expanding capabilities in pharmaceutical closure solutions and strengthening its market position in advanced packaging technologies for the pharmaceutical industry.
- September 2022 : Amcor plc secured a major contract with a leading pharmaceutical company for its innovative AmSky packaging system, demonstrating market confidence in advanced pharmaceutical packaging solutions and supporting the company's growth in specialized closure technologies.
- August 2022 : Gerresheimer AG completed the acquisition of flexible packaging capabilities to expand its product offerings in the pharmaceutical packaging sector, broadening its portfolio of closure solutions and strengthening its position in the global pharmaceutical caps and closures market.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Caps and Closure Packaging Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Still Researching the
Pharmaceutical Caps and Closure Packaging Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.
Growth opportunities and latent adjacency in Pharmaceutical Caps and Closure Packaging Market